Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: Immunohistochemical reactivity correlates with karyotypic alterations

American Journal of Pathology

Volumn 151, Issue 1, 1997, Pages 37-43

  Tallini, Giovanni ^a   Cin, Paola Dal ^c   Rhoden, Kerry J ^a,b   Chiapetta, Gennaro ^d   Manfioletti, Guidalberto ^e   Giancotti, Vincenzo ^e   Fusco, Alfredo ^f   Van den Berghe, Herman ^c   Sciot, Raf ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHN B PIERCE LABORATORY   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY OF TRIESTE   (Italy)

^f UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP PROTEIN;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME 12Q; CHROMOSOME 6P; CLINICAL ARTICLE; GENE LOCATION; GENE REARRANGEMENT; GENETIC LINKAGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIPOMA; LIPOMATOSIS; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN SYNTHESIS REGULATION; TUMOR BIOPSY;

ADULT; CHROMOSOME ABERRATIONS; HIGH MOBILITY GROUP PROTEINS; HMGA1A PROTEIN; HMGA2 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LIPOMA; LIPOSARCOMA; NEOPLASM PROTEINS; SOFT TISSUE NEOPLASMS;

EID: 1842332673     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Lovell-Badge R: Living with bad architecture. Nature 1995, 376:725-726
2. Johnson KR, Lehn DA, Elton TS, Barr PJ, Reeves R: Complete murine cDNA sequence, genomic structure and tissue expression of the high mobility group protein HMGI(Y). J Biol Chem 1988, 263:18338-18342
3. Manfioletti G, Giancotti V, Bandiera A, Buratti E, Sautiere P, Cary P, Crane-Robinson C, Coles B, Goodwin GH: cDNA cloning of the HMGI-C phosphoprotein, a nuclear protein associated with neoplastic and undifferentiated phenotypes. Nucleic Acids Res 1991, 19:6793-6797
4. Ashar HR, Schoenberg Fejzo M, Tkachenko A, Zhou X, Reicher JA, Weremowicz S, Morton CC, Chada K: Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains. Cell 1995, 82:57-65
5. Chau KY, Patel DA, Lee KLD, Lam HYP, Crane-Robinson C: The gene for the human architectural transcription factor HMGI-C consists of five exons each coding for a distinct functional element. Nucleic Acids Res 1995, 23:4262-4266
6. Friedman M, Holth LT, Zoghbi HY, Reeves R: Organization, inducible expression and chromosome localization of the human HMG-I(Y) non-histone protein gene. Nucleic Acids Res 1993, 21:4259-4267
7. Manfioletti G, Rustiglio A, Mantovani F, Goodwin GH, Giancotti V: Isolation and characterization of the gene coding for murine high-mobility group protein HMGI-C. Gene 1995, 167:249-253
8. Giancotti V, Bandiera A, Buratti E, Fusco F, Marzari R, Coles B, Goodwin GH: Comparison of multiple forms of the high mobility group I proteins in rodent and human cells, identification of the human high mobility group I-C protein. Eur J Biochem 1991, 198:211-216
9. Giancotti V, Bandiera A, Ciani L, Santoro D, Crane-Robinson C, Goodwin GH, Boiocchi M, Dolcetti R, Casetta B: High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissue of mouse. Eur J Biochem 1993, 211:825-832
10. Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, Bullerdiek J: HMGI-C expression patterns in human tissues: implications for the genesis of frequent mesenchymal tumors. Am J Pathol 1996, 149:775-779
11. Zhou S, Benson KF, Ashar HR, Chada K: Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 1995, 376:771-774
12. Bussemakers MJG, Van de Ven WJM, Debruyne FMJ, Schalken J: Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res 1991, 51:606-611
13. Chiapetta G, Bandiera A, Berlingieri MT, Visconti R, Manfioletti G, Battista S, Martinez-Tello FJ, Santoro M, Giancotti V, Fusco A: The expression of the high mobility group HMGI(Y) proteins correlates with the malignant phenotype of human thyroid neoplasms. Oncogene 1996, 10:1307-1314
14. Fedele M, Bandiera A, Chiappetta G, Battista S, Viglietto G, Manfioletti G, Casamassimi A, Santoro M, Giancotti V, Fusco A: Human colorectal carcinomas express high levels of high mobility group HMGI(Y) proteins. Cancer Res 1996, 56:1896-1901
15. Giancotti V, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Crane-Robinson C: Changes in nuclear proteins following transformation of rat thyroid epithelial cells by a murine sarcoma retrovirus. Cancer Res 1985, 45:6051-6057
16. Giancotti V, Pani B, D'Andrea P, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Philip R, Crane-Robinson C, Nicolas RH, Wright CA, Goodwin GH: Elevated levels of a specific class of nuclear phosphoroproteins in cells transformed with ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T genes. EMBO J 1987, 6:1981-1987
17. Ram TG, Reeves R, Hosick HL: Elevated high mobility group I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res 1993, 53:2655-2660
18. Berlingieri MT, Manfioletti G, Santoro M, Bandiera A, Visconti R, Giancotti V, Fusco A: Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells. Mol Cell Biol 1995, 15:1545-1553
19. Schoenmakers EFPM, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJM: Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumors. Nature Genet 1995, 10:436-444
20. Mitelman F: Catalog of Chromosomal Aberration in Cancer, ed 5. New York, Wiley Liss, 1994
21. Petit MMR, Mols R, Schoenmakers EFPM, Mandahl N, Van de Ven WJM: LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of he LIM protein gene family. Genomics 1996, 36:118-129
22. Flether CDM, Akerman M, Dal Cin P, DeWever I, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Van De Ven W, Vanni R, Willen H: Correlation between clinicopathologic features and karyotype in lipomatous tumors: a report of 177 cases from the chromosome and morphology (CHAMP) collaborative study group. Am J Pathol 1996, 148:623-630
23. Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven WJM, Kayser K, Krieghoff B, Kastendiek H, Bartnitzke S, Bullerdiek J: HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene 1996, 12:515-521
24. Kazmierczak B, Wanschura S, Rommel B, Bartnitzke S, Bullerdiek J: Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMG-I(Y) gene or its immediate surroundings. J Natl Cancer Inst 1996, 88:1234-1236
25. Rosai J, Akerman M, Dal Cin P, DeWever I, Fletcher CDM, Mandahl N, Mertens F, Mitelman F, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Van De Ven W, Vanni R, Willen H: Combined morphologic and karyotypic study of 59 atypical lipomatous tumors: evaluation of their relationship and differential diagnosis with other adipose tissue tumors (a report of the CHAMP Study Group). Am J Surg Pathol 1996, 20:1182-1189
26. Dal Cin P, Kools P, Sciot R, De Wever I, Van Damme B, Van de Ven W, Van Den Berghe H: Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet 1993, 68:85-90
27. Berner JM, Forus A, Elkahloun A, Meltzer PS, Fodstad O, Myklebost O: Separate amplified regions encompassing CDK4 and MDM2 and human sarcomas. Genes Chromosomes & Cancer 1996, 17:254-259
28. Elkahloun AG, Bittner M, Hoskins K, Gemmill R, Meltzer PS: Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancers. Genes Chromosomes of Cancer 1996, 17:205-214
29. Nilbert M, Rydholm A, Mitelman F, Meltzer PS, Mandahl N: Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet 1995, 83:32-36
30. Wolf M, Aaltonen LA, Szymansha J, Tarkkanen M, Elomaa I, Knuutila S: Microsatellite markers as tools for characterization of DNA amplifications evaluated by comparative genomic hybridization. Cancer Genet Cytogenet 1997, 20:1-6
31. Tallini G, Buckley PJ, West AB: Diagnosis of gastrointestinal T-cell lymphomas in routinely processed tissue. J Clin Gastroenterol 1993, 17:57-66
32. Ashar HR, Cerath L, Przybysz KM, Chada K: Genomic characterization of human HMGIC, a member of the accessory transcription factor family found at translocation breakpoints in lipomas. Genomics 1996, 31:207-214
33. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ: Molecular abnormalities of MDM2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994, 54:794-799
34. Mandahl N, Akerman M, Aman P, Dal Cin P, De Wever I, Fletcher CDM, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, Van Den Berghe H, Van De Ven W, Vanni R, Willen H: Duplication of chromosome segment 12q15-24 is associated with atypical lipomatous tumors: a report of the CHAMP collaborative study group. Int J Cancer 1996, 67:632-635